Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
Rupesh Kotecha, Raees Tonse, Haley Appel, et al.
Current Oncology (2021) Vol. 28, Iss. 2, pp. 1537-1543
Open Access | Times Cited: 11

Showing 11 citing articles:

EANO guideline on molecular testing of meningiomas for targeted therapy selection
Felix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 6
A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy
Iuliana Mihaela Buzatu, Ligia Gabriela Tătăranu, C. Duta, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2192-2192
Open Access
Diarylpentanoid, a curcumin analog, inhibits malignant meningioma growth in both in vitro and in vivo models
Akihiro Terasawa, Kazuhiro Shimazu, Hiroshi Nanjo, et al.
World Journal of Experimental Medicine (2025) Vol. 15, Iss. 2
Closed Access
Chemotherapy and targeted therapies for meningiomas: what is the evidence?
Thomas Graillon, Émeline Tabouret, Olivier Chinot
Current Opinion in Neurology (2021) Vol. 34, Iss. 6, pp. 857-867
Closed Access | Times Cited: 23
Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review
Atsushi Okano, Satoru Miyawaki, Yu Teranishi, et al.
Neurologia medico-chirurgica (2022) Vol. 62, Iss. 8, pp. 347-360
Open Access | Times Cited: 9
A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase Inhibitor
Teboho Moerane, Vuyiswa Kama
(2023)
Open Access | Times Cited: 1
Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma
Rafael Roesler, Bárbara Kunzler Souza, Gustavo Rassier Isolan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11352-11352
Open Access | Times Cited: 3
Beating a benchmark: Boron neutron capture therapy for recurrent and refractory meningiomas
Martin C. Tom, Rupesh Kotecha
Neuro-Oncology (2021) Vol. 24, Iss. 1, pp. 99-100
Open Access | Times Cited: 2
Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers in Meningioma
Rafael Roesler, Bárbara Kunzler Souza, Gustavo Rassier Isolan
(2021)
Open Access | Times Cited: 1
A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase Inhibitor
Teboho Alfred Moerane
(2023)
Open Access
A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase Inhibitor
Teboho Alfred Moerane
(2023)
Open Access
Page 1

Scroll to top